The U.S. Food and Drug Administration announced the approval of the first hematopoietic stem cell transplant therapy to treat ...

Immunotherapy has revolutionized cancer care by training the immune system to detect and destroy tumors. For many patients, ...

STEM-engineered CAR T cells performed as well as or better against cancer cells than did FDA-approved CAR T cells and kept their cancer-fighting abilities for longer.

New research is challenging one of medicine’s oldest assumptions: that cancer must be attacked to be cured. By treating ...

Researchers from the Keck School of Medicine of USC have developed a new type of chimeric antigen receptor (CAR) T cell that ...

A breakthrough therapy is driving aggressive leukaemia into remission. Here’s what the headlines don’t tell you about life ...

A cutting-edge therapy using base-edited immune cells is offering a major breakthrough for patients with one of the toughest ...

Lung cancer patients who received IV immunotherapy doses earlier in the day tended to live longer, researchers reported in a ...

Juvenile Myelomonocytic Leukemia, or JMML, is a rare and aggressive childhood blood cancer that mostly affects kids under ...

USC researchers have developed a new type of chimeric antigen receptor (CAR) T cell that elicits a more controlled immune response to cancer in mice—effectively killing cancer cells, including those ...